Wright Medical Group NV (Wright Medical Group NV) EPS (Diluted) : $-0.85 (TTM As of Sep. 2020)

View and export this data going back to 2011. Start your Free Trial

What is Wright Medical Group NV EPS (Diluted)?

Wright Medical Group NV's Earnings per Share (Diluted) for the three months ended in Sep. 2020 was $-0.15. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.85.

Wright Medical Group NV's EPS (Basic) for the three months ended in Sep. 2020 was $-0.15. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.85.

Wright Medical Group NV's EPS without NRI for the three months ended in Sep. 2020 was $-0.13. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.68.

During the past 3 years, the average EPS without NRIGrowth Rate was 24.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 30.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, Wright Medical Group NV's highest 3-Year average EPS without NRI Growth Rate was 48.40% per year. The lowest was -101.00% per year. And the median was 24.40% per year.

Wright Medical Group NV EPS (Diluted) Historical Data

The historical data trend for Wright Medical Group NV's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wright Medical Group NV EPS (Diluted) Chart

Wright Medical Group NV Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

EPS (Diluted)

Get a 7-Day Free Trial

-4.61

-4.20

-1.94

-1.51

-0.90

Wright Medical Group NV Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
EPS (Diluted)	Get a 7-Day Free Trial															-0.35	-0.12	-0.12	-0.46	-0.15

Competitive Comparison of Wright Medical Group NV's EPS (Diluted)

For the Medical Devices subindustry, Wright Medical Group NV's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wright Medical Group NV's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wright Medical Group NV's PE Ratio distribution charts can be found below:

* The bar in red indicates where Wright Medical Group NV's PE Ratio falls into.

Wright Medical Group NV EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Wright Medical Group NV's Diluted EPS for the fiscal year that ended in Dec. 2019 is calculated as

Diluted EPS (A: Dec. 2019 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-114.225	-	0)	/	126.601
	=	-0.90

Wright Medical Group NV's Diluted EPS for the quarter that ended in Sep. 2020 is calculated as

Diluted EPS (Q: Sep. 2020 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-19.722	-	0)	/	129.463
	=	-0.15

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.85

Wright Medical Group NV (NAS:WMGI) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Wright Medical Group NV EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Wright Medical Group NV's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Wright Medical Group NV (Wright Medical Group NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group NV (NAS:WMGI) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB

Website

http://www.wright.com

Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sports medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.

Executives

Steven P. Wallace	officer: President, International	1023 CHERRY ROAD MEMPHIS TN 38117
Barry J. Regan	officer: SVP, Operations	1023 CHERRY ROAD, MEMPHIS TN 38117
Kevin C. Smith	officer: SVP, Quality and Regulatory	1023 CHERRY ROAD MEMPHIS TN 38117
Jason D. Asper	officer: SVP, Chief Digital Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Tim Lanier	officer: President, Upper Extremities	1023 CHERRY ROAD MEMPHIS TN 38117
Patrick Fisher	officer: President, Lower Extremities	1023 CHERRY ROAD MEMPHIS TN 38117
Jonathan Wesley Porter	officer: SVP, Chief Compliance Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Julie Andrews	officer: SVP, Global Finance	5677 AIRLINE ROAD, ARLINGTON TN 38002
Jennifer S. Walker	officer: SVP, Process Improvement	5677 AIRLINE ROAD ARLINGTON TN 38002
Andrew C. Morton	officer: SVP, Chief Human Resources Ofr	10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Lance A Berry	officer: EVP, Chief Finan./Op. Officer	5677 AIRLINE ROAD, ARLINGTON TN 38002
Julie D. Dewey	officer: SVP, Chief Comm. Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Kevin D Cordell	officer: EVP, Chief Global Comm Officer	C/O WRIGHT MEDICAL GROUP, INC. 1023 CHERRY ROAD MEMPHIS TN 38117
Robert J Palmisano	director, officer: President and Chief Executive	110 HARTWELL AVENUE, LEXINGTON MA 02173
Peter Cooke	officer: Pres. Emerging Markets AUS/JAP	5677 AIRLINE ROAD ARLINGTON TN 38002